Eledon Pharmaceuticals, Inc. (ELDN) vs Yarrow Bioscience, Inc (YARW)

Eledon Pharmaceuticals, Inc. and Yarrow Bioscience, Inc are both Biotechnology companies. Eledon Pharmaceuticals, Inc. and Yarrow Bioscience, Inc are of similar size ($188.8M and $184.5M). Eledon Pharmaceuticals, Inc. has the higher net margin (0.00% vs −3,881.5%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, Yarrow Bioscience, Inc leads on 7 and Eledon Pharmaceuticals, Inc. on 5.

Valuation

Metric ELDN YARW Biotechnology median
P/E n/m n/m 8.50
P/S n/m 33.43 9.71
P/B 7.33 0.73 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m 124.14 9.21
Earnings yield (42.72%) (107.97%) (33.15%)
Free cash flow yield (30.51%) (106.25%) (25.50%)

Profitability

Metric ELDN YARW Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% (4,134.44%) 0.00%
Net margin 0.00% (3,881.54%) 0.00%
Free cash flow margin 0.00% (3,513.07%) 0.00%
Return on equity (236.51%) (61.40%) (56.36%)
Return on assets (72.74%) (54.77%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ELDN YARW Biotechnology median
Revenue growth (TTM) — 1.26% 6.02%
EPS growth (last fiscal year) 30.67% 32.26% 30.26%
Revenue growth, 5-year CAGR — (51.39%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ELDN YARW Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 7.90 15.26 4.72
Net debt to EBITDA 1.60 0.95 0.96

Dividend

Metric ELDN YARW Biotechnology median
Dividend yield — 0.09% 0.09%
Payout ratio — — —

Size

Metric ELDN YARW Biotechnology median
Market cap 184.47m 188.75m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack